Table 2. Cross-tabulation of central pathology or surgical review and MRI results. CI confidence interval.
| Central pathology/surgical review | |||||
|---|---|---|---|---|---|
| Yes | No | Indeterminate | |||
| MRI results for capsular penetration | Penetrated | 22 | 6 | 5 | |
| Intact | 13 | 31 | 5 | ||
| Total | 35 | 37 | 10 | ||
| Sensitivity: 22/35 = 62.9%; 95% CI: 44.9%, 78.0% Specificity: 31/37 = 83.8%; 95% CI: 67.3%, 93.2% | |||||
| MRI results for lymph node involvement | Positive | Negative | No lymph nodes sampled | ||
| Positive | 9 | 4 | 2 | ||
| Negative | 8 | 48 | 11 | ||
| Total | 17 | 52 | 13 | ||
| Sensitivity: 9/17 = 52.9%; 95% CI: 28.5%, 76.1% Specificity: 48/52 = 92.3%; 95% CI: 80.6%, 97.5% | |||||
| MRI results for venous extension | Inferior vena cava | Renal vein | No | Indeterminate | |
| Inferior vena cava | 1 | 0 | 0 | 0 | |
| Renal vein | 0 | 0 | 1 | 1 | |
| No | 0 | 3 | 72 | 4 | |
| Total | 1 | 3 | 73 | 5 | |
| Sensitivity: 1/4 = 25.0%. 95% CI: (1.3%, 78.1%). Specificity: 72/73 = 98.6%. 95% CI: (91.6%, 99.9%). | |||||
| MRI results for tumor rupture | Yes | No | Indeterminate | ||
| Yes | 1 | 3 | 1 | ||
| No | 1 | 74 | 2 | ||
| Total | 2 | 77 | 3 | ||
| Sensitivity: 1/2 = 50.0%; 95% CI: 2.7%, 97.3% Specificity: 74/77 = 96.1%; 95% CI: 88.3%, 99.0% | |||||